Hypermethylation of SOX2 gene in hydatidiform mole and choriocarcinoma

Reproductive Sciences

Volumn 15, Issue 7, 2008, Pages 735-744

  Li, Albert S M ^a   Siu, Michelle K Y ^a   Zhang, HuiJuan ^a   Wong, Esther S Y ^a   Chan, Kelvin Y K ^a   Ngan, Hextan Y S ^a   Cheung, Annie N Y ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Choriocarcinoma; Hydatidiform mole; Methylation; Placenta; SOX2

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; TRANSCRIPTION FACTOR SOX2; TRICHOSTATIN A;

ARTICLE; CHORIOCARCINOMA; CONTROLLED STUDY; DRUG POTENTIATION; EPIGENETICS; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE SEQUENCE; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; HYDATIDIFORM MOLE; METHYLATION; PLACENTA; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADOLESCENT; ADULT; CELL LINE, TUMOR; CHORIOCARCINOMA; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDATIDIFORM MOLE; MIDDLE AGED; PREGNANCY; SOXB1 TRANSCRIPTION FACTORS; UTERINE NEOPLASMS; YOUNG ADULT;

EID: 52449132308     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719108322433     Document Type: Article

References (47)

1. Esteller M. Epigenetics provides a new generation of oncogenes and tumour-suppressor genes. Br J Cancer. 2006 ; 96 (suppl): R26 - R30.
2. Fraga MF, Esteller M. Towards the human cancer epigenome: a first draft of histone modifications. Cell Cycle. 2005 ; 4: 1377-1381.
3. Strickland S., Richards WG Invasion of the trophoblasts. Cell. 1992 ; 71: 355-357.
4. Smith HO Gestational trophoblastic disease epidemiology and trends. Clin Obstet Gynecol. 2003 ; 46: 541-556.
5. Royal College of Obstetricians and Gynaecologists (RCOG). The management of gestational trophoblastic neoplasia (Guideline; no. 38). London, UK: Royal College of Obstetricians and Gyneacologists (RCOG). 2004 ; 1-7.
6. Sattler HP, Lensch R., Rohde V., et al. Novel amplification unit at chromosome 3q25-q27 in human prostate cancer. Prostate. 2000 ; 45: 207-215.
7. Wiebe MS, Wilder PJ, Kelly D., et al. Isolation, characterization, and differential expression of the murine Sox2 promoter. Gene. 2000 ; 246: 383-393.
8. Sinclair AH, Berta P., Palmer MS, et al. A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif. Nature. 1990 ; 346: 240-244.
9. Kamachi Y., Uchikawa M., Kondoh H. Pairing SOX off. Trends Genet. 2000 ; 16: 182-187.
10. Boer B., Kopp J., Mallanna S., et al. Elevating the levels of Sox2 in embryonal carcinoma cells and embryonic stem cells inhibits the expression of Sox2:Oct-3/4 target genes. Nucleic Acids Res. 2007 ; 35: 1773-1786.
11. Wegner M. From head to toes: the multiple facets of Sox proteins. Nucleic Acids Res. 1999 ; 27: 1409-1420.
12. Yuan H., Corbi N., Basilico C., et al. Developmental specific activity of the FGF-4 enhancer requires the synergistic action of Sox2 and Oct-3. Genes Dev. 1995 ; 9: 2635-2645.
13. Avilion AA, Nicolis SK, Pevny LH, et al. Multipotent cell lineages in early mouse development depend on Sox2 function. Genes Dev. 2003 ; 17: 126-140.
14. Niwa H., Toyooka Y., Shimosato D., et al. Interaction between Oct3/4 and Cdx2 determines trophectoderm differentiation. Cell. 2005 ; 123: 917-929.
15. Babaie Y., Herwig R., Greber B., et al. Analysis of Oct4-dependent transcriptional networks regulating self-renewal and pluripotency in human embryonic stem cells. Stem Cells. 2007 ; 25: 500-510.
16. Li J., Pan G., Cui K., et al. A dominant-negative form of mouse SOX2 induces trophectoderm differentiation and progressive polyploidy in mouse embryonic stem cells. J Biol Chem. 2007 ; 282: 19481-19492.
17. Shih IM, Mazur MT, Kurman RJ Gestational trophoblastic disease and related lesion. In: Kurman RJ, ed. Blaustein's Pathology of the Female Genital Tract. 5 th ed. New York: Springer ; 2002: 1193-1250.
18. Paradinas FJ, Elston CW Gestational trophoblastic disease. Haines and Taylor: Obstetrical and Gynaecological Pathology. In: Fox H, Wells M, eds. Edinburgh: Churchill Livingstone; 2003: 1359-1430.
19. Cheung AN Pathology of gestational trophoblastic diseases. Best Pract Res Clin Obstet Gynaecol. 2003 ; 17: 849-868.
20. Lai CY, Chan KY, Khoo US, et al. Analysis of gestational trophoblastic disease by genotyping and chromosome in situ hybridization. Mod Pathol. 2004 ; 17: 40-48.
21. Cheung AN, Khoo US, Lai CY, et al. Metastatic trophoblastic disease after an initial diagnosis of partial hydatidiform mole: genotyping and chromosome in situ hybridization analysis. Cancer. 2004 ; 100: 1411-1417.
22. Ngan HY, Chan KY, Tam KF Gestational trophoblastic disease. Curr Obstet Gynaecol. 2006 ; 16: 93-99.
23. Xue WC, Feng HC, Tsao SW, et al. Methylation status and expression of E-cadherin and cadherin-11 in gestational trophoblastic diseases. Int J Gynecol Cancer. 2003 ; 13: 879-888.
24. Xue WC, Chan KY, Feng HC, et al. Promoter hypermethylation of multiple genes in hydatidiform mole and choriocarcinoma. J Mol Diagn. 2004 ; 6: 326-334.
25. Li LC, Dahiya R. MethPrimer: designing primers for methylation PCRs. Bioinformatics. 2002 ; 18: 1427-1431.
26. Feng HC, Tsao SW, Ngan HY, et al. Overexpression of prostate stem cell antigen is associated with gestational trophoblastic neoplasia. Histopathology. 2008 ; 52: 167-174.
27. Shen DH, Chan KY, Khoo US, et al. Epigenetic and genetic alterations of p33ING1b in ovarian cancer. Carcinogenesis. 2005 ; 26: 855-863.
28. Feng H., Cheung AN, Xue WC, et al. Down-regulation and promoter methylation of tissue inhibitor of metalloproteinase 3 in choriocarcinoma. Gynecol Oncol. 2004 ; 94: 375-382.
29. Meng CF, Zhu XJ, Peng G., et al. Re-expression of methylation-induced tumor suppressor gene silencing is associated with the state of histone modification in gastric cancer cell lines. World J Gastroenterol. 2007 ; 13: 6166-6171.
30. Ben-Porath I., Cedar H. Epigenetic crosstalk. Mol Cell. 2001 ; 8: 933-935.
31. Fahrner JA, Eguchi S., Herman JG, et al. Dependence of histone modifications and gene expression on DNA hypermethylation in cancer. Cancer Res. 2002 ; 62: 7213-7218.
32. Fuks F., Burgers WA, Brehm A., et al. DNA methyltransferase Dnmt1 associates with histone deacetylase activity. Nat Genet. 2000 ; 24: 88-91.
33. Rountree MR, Bachman KE, Baylin SB DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci. Nat Genet. 2000 ; 25: 269-277.
34. Christman JK 5-Azacytidine and 5-aza-2'-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy. Oncogene. 2002 ; 21: 5483-5495.
35. Donadelli M., Costanzo C., Faggioli L., et al. Trichostatin A, an inhibitor of histone deacetylases, strongly suppresses growth of pancreatic adenocarcinoma cells. Mol Carcinog. 2003 ; 38: 59-69.
36. Li X., Kato Y., Tsuji Y., et al. The effects of trichostatin a on mRNA expression of chromatin structure-, DNA methylation-, and development-related genes in cloned mouse blastocysts. Cloning Stem Cells. 2008 ; 10: 133-142.
37. Santagata S., Ligon KL, Hornick JL Embryonic stem cell transcription factor signatures in the diagnosis of primary and metastatic germ cell tumors. Am J Surg Pathol. 2007 ; 31: 836-845.
38. Cameron EE, Bachman KE, Myöhänen S., et al. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat Genet. 1999 ; 21: 103-107.
39. Torres-Padilla ME, Parfitt DE, Kouzarides T., et al. Histone arginine methylation regulates pluripotency in the early mouse embryo. Nature. 2007 ; 445: 214-218.
40. Dong C., Wilhelm D., Koopman P. Sox genes and cancer. Cytogenet Genome Res. 2004 ; 105: 442-447.
41. Li XL, Eishi Y., Bai YQ, et al. Expression of the SRY-related HMG box protein SOX2 in human gastric carcinoma. Int J Oncol. 2004 ; 24: 257-263.
42. Hemmati HD, Nakano I., Lazareff JA, et al. Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci USA. 2003 ; 100: 15178-15183.
43. Gu G., Yuan J., Wills M., et al. Prostate cancer cells with stem cell characteristics reconstitute the original human tumor in vivo. Cancer Res. 2007 ; 67: 4807-4815.
44. Rodriguez-Pinilla SM, Sarrio D., Moreno-Bueno G., et al. SOX2: a possible driver of the basal-like phenotype in sporadic breast cancer. Mod Pathol. 2007 ; 20: 474-481.
45. Rahnama F., Shafiei F., Gluckman PD, et al. Epigenetic regulation of human trophoblastic cell migration and invasion. Endocrinology. 2006 ; 147: 5275-5283.
46. Otsubo T., Akiyama Y., Yanagihara K., et al. SOX2 is frequently downregulated in gastric cancers and inhibits cell growth through cell-cycle arrest and apoptosis. Br J Cancer. 2008 ; 98: 824-831.
47. Zhang HJ, Siu MK, Wong ES Wong, et al. Oct4 is epigenetically regulated by methylation in normal placenta and gestational trophoblastic disease. Placenta 2008 ; 29: 549-554.